Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway

Abstract Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis. Although a number of antioxidants are available, none have been found to be suitable for regulating the oxidative stress response and en...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 211; no. 1; pp. 69 - 76
Main Authors Hur, Kyu Yeon, Kim, Soo Hyun, Choi, Min-Ah, Williams, Darren R, Lee, Yong-ho, Kang, Sang Won, Yadav, Umesh C.S, Srivastava, Satish K, Jung, Mankil, Cho, Jin Won, Kim, Sang Geon, Kang, Eun Seok, Lee, Eun Jig, Lee, Hyun Chul
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ireland Ltd 01.07.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis. Although a number of antioxidants are available, none have been found to be suitable for regulating the oxidative stress response and enhancing antioxidative defense mechanisms. In this study, we evaluated the effects of magnesium lithospermate B (LAB) against oxidative stress. We also endeavored to identify the target molecule of LAB in vascular smooth muscle cells (VSMCs) and the underlying biochemical pathways related to diabetic atherosclerosis. Modified MTT and transwell assays showed that the increased proliferation and migration of rat aortic VSMCs in culture with high glucose was significantly inhibited by LAB. LAB also attenuated neointimal hyperplasia after balloon catheter injury in diabetic rat carotid arteries. To determine molecular targets of LAB, we studied the effects of LAB on aldose reductase (AR) activity, O-GlcNAcylation, and protein kinase C (PKC) activity in VSMCs under normoglycemic or hyperglycemic conditions and showed the improvement of major biochemical pathways by LAB. Potential involvement of the nuclear factor erythroid 2-related factor-2 (Nrf2) – antioxidant responsive element (ARE)-NAD(P)H: quinone oxidoreductase-1 (NQO1) pathway was assessed using siRNA methods. We found that LAB activates the NQO1 via the Nrf2-ARE pathway, which plays an important role in inhibition of the major molecular mechanisms that lead to vascular damage and the proliferation and migration of VSMCs. Together, these findings demonstrate that the induction of the Nrf2-ARE-NQO1 pathway by LAB could be a new therapeutic strategy to prevent diabetic atherosclerosis.
AbstractList Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis. Although a number of antioxidants are available, none have been found to be suitable for regulating the oxidative stress response and enhancing antioxidative defense mechanisms. In this study, we evaluated the effects of magnesium lithospermate B (LAB) against oxidative stress. We also endeavored to identify the target molecule of LAB in vascular smooth muscle cells (VSMCs) and the underlying biochemical pathways related to diabetic atherosclerosis. Modified MTT and transwell assays showed that the increased proliferation and migration of rat aortic VSMCs in culture with high glucose was significantly inhibited by LAB. LAB also attenuated neointimal hyperplasia after balloon catheter injury in diabetic rat carotid arteries. To determine molecular targets of LAB, we studied the effects of LAB on aldose reductase (AR) activity, O-GlcNAcylation, and protein kinase C (PKC) activity in VSMCs under normoglycemic or hyperglycemic conditions and showed the improvement of major biochemical pathways by LAB. Potential involvement of the nuclear factor erythroid 2-related factor-2 (Nrf2)--antioxidant responsive element (ARE)-NAD(P)H: quinone oxidoreductase-1 (NQO1) pathway was assessed using siRNA methods. We found that LAB activates the NQO1 via the Nrf2-ARE pathway, which plays an important role in inhibition of the major molecular mechanisms that lead to vascular damage and the proliferation and migration of VSMCs. Together, these findings demonstrate that the induction of the Nrf2-ARE-NQO1 pathway by LAB could be a new therapeutic strategy to prevent diabetic atherosclerosis.
Abstract Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis. Although a number of antioxidants are available, none have been found to be suitable for regulating the oxidative stress response and enhancing antioxidative defense mechanisms. In this study, we evaluated the effects of magnesium lithospermate B (LAB) against oxidative stress. We also endeavored to identify the target molecule of LAB in vascular smooth muscle cells (VSMCs) and the underlying biochemical pathways related to diabetic atherosclerosis. Modified MTT and transwell assays showed that the increased proliferation and migration of rat aortic VSMCs in culture with high glucose was significantly inhibited by LAB. LAB also attenuated neointimal hyperplasia after balloon catheter injury in diabetic rat carotid arteries. To determine molecular targets of LAB, we studied the effects of LAB on aldose reductase (AR) activity, O-GlcNAcylation, and protein kinase C (PKC) activity in VSMCs under normoglycemic or hyperglycemic conditions and showed the improvement of major biochemical pathways by LAB. Potential involvement of the nuclear factor erythroid 2-related factor-2 (Nrf2) – antioxidant responsive element (ARE)-NAD(P)H: quinone oxidoreductase-1 (NQO1) pathway was assessed using siRNA methods. We found that LAB activates the NQO1 via the Nrf2-ARE pathway, which plays an important role in inhibition of the major molecular mechanisms that lead to vascular damage and the proliferation and migration of VSMCs. Together, these findings demonstrate that the induction of the Nrf2-ARE-NQO1 pathway by LAB could be a new therapeutic strategy to prevent diabetic atherosclerosis.
Author Lee, Yong-ho
Lee, Hyun Chul
Lee, Eun Jig
Kim, Soo Hyun
Jung, Mankil
Hur, Kyu Yeon
Yadav, Umesh C.S
Williams, Darren R
Kang, Sang Won
Srivastava, Satish K
Cho, Jin Won
Kim, Sang Geon
Kang, Eun Seok
Choi, Min-Ah
Author_xml – sequence: 1
  fullname: Hur, Kyu Yeon
– sequence: 2
  fullname: Kim, Soo Hyun
– sequence: 3
  fullname: Choi, Min-Ah
– sequence: 4
  fullname: Williams, Darren R
– sequence: 5
  fullname: Lee, Yong-ho
– sequence: 6
  fullname: Kang, Sang Won
– sequence: 7
  fullname: Yadav, Umesh C.S
– sequence: 8
  fullname: Srivastava, Satish K
– sequence: 9
  fullname: Jung, Mankil
– sequence: 10
  fullname: Cho, Jin Won
– sequence: 11
  fullname: Kim, Sang Geon
– sequence: 12
  fullname: Kang, Eun Seok
– sequence: 13
  fullname: Lee, Eun Jig
– sequence: 14
  fullname: Lee, Hyun Chul
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23056072$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20172524$$D View this record in MEDLINE/PubMed
BookMark eNqNkstuGyEUhlGVqnHSvkLFJupq3MPAeGDRSmmUJpWipNc1YphDgjsXBxhX7tMHy24WXnUDSHz_ufznnJCjYRyQkDMGcwZs8X45N-kBwxhttz19nJeQ_4DNgVcvyIzJWhVMSHFEZgAlKxSr4JicxLgEAFEz-YocZ0ldVqWYkb9fw5jQJr9Gis7lV6Sjo725HzD6qaedTw9jXGHoTUL6iZp744eYaOtNg8lbelAOXXtDb4Mri_Pvl8XttztGUzBDtMGvkh8H09FVlvwxm9fkpTNdxDf7-5T8-nz58-K6uLm7-nJxflPYiqtUCNtyUNyZmglWObmQAM2ilNgKZEqxpmkZlkpU3ErEslXcCCeVlSAcKCH5KXm3i7sK4-OEMeneR4tdZwYcp6hrzlVdc4BMftiRNrcSAzq9Cr43YaMZ6K37eqkP2tVb9zUwnd3P-rf7TFPTY_us_md3Bs72gInWdC4bY3OMZ45DtYC6zNzVjsPsy9pj0NF6HCy2PuQR6Xb0_13Sx4NItvODz8l_4wbjcpxCHknUTMdSg_6xXZntxrC8LCA5509wDMTU
CitedBy_id crossref_primary_10_1371_journal_pone_0098232
crossref_primary_10_1038_s41401_018_0189_1
crossref_primary_10_1155_2017_9237263
crossref_primary_10_1016_j_vph_2018_08_009
crossref_primary_10_1155_2016_5749857
crossref_primary_10_2174_1389200221666201016124125
crossref_primary_10_1016_j_jff_2015_01_042
crossref_primary_10_3390_antiox11061072
crossref_primary_10_1038_aps_2012_126
crossref_primary_10_3389_fbioe_2022_913791
crossref_primary_10_1007_s10753_019_01125_8
crossref_primary_10_1016_j_phymed_2020_153419
crossref_primary_10_1002_ptr_7137
crossref_primary_10_1155_2012_216512
crossref_primary_10_1152_ajpcell_00294_2019
crossref_primary_10_1016_j_jep_2013_11_036
crossref_primary_10_1016_j_seizure_2017_07_014
crossref_primary_10_3390_life11121301
crossref_primary_10_2174_2210315513666230427153251
crossref_primary_10_1016_j_fct_2018_07_061
crossref_primary_10_1155_2019_1394641
crossref_primary_10_1007_s11655_017_2546_6
crossref_primary_10_1016_j_cellsig_2011_05_016
crossref_primary_10_1139_cjpp_2021_0488
crossref_primary_10_1016_j_taap_2011_01_018
crossref_primary_10_1002_tox_23313
crossref_primary_10_1155_2017_5671860
crossref_primary_10_1007_s12012_015_9353_8
crossref_primary_10_1016_j_cotox_2016_08_001
crossref_primary_10_1152_ajpendo_00430_2012
crossref_primary_10_1016_j_biotechadv_2017_12_015
crossref_primary_10_1016_j_bcp_2012_04_021
crossref_primary_10_1007_s12011_019_01922_0
crossref_primary_10_1155_2013_247948
crossref_primary_10_1007_s00411_014_0551_8
crossref_primary_10_1007_s12012_011_9136_9
crossref_primary_10_1155_2017_4826724
crossref_primary_10_1155_2018_3549312
crossref_primary_10_1016_j_bbrc_2011_06_071
crossref_primary_10_1155_2017_2070178
crossref_primary_10_3390_antiox12010082
crossref_primary_10_3389_fendo_2021_598005
crossref_primary_10_1007_s11892_013_0372_1
crossref_primary_10_1016_j_phrs_2014_10_004
crossref_primary_10_1021_acs_jnatprod_5b00348
crossref_primary_10_1038_s41598_017_14733_x
crossref_primary_10_1016_j_freeradbiomed_2015_06_019
crossref_primary_10_1080_14728222_2016_1250887
Cites_doi 10.1210/er.2001-0039
10.1016/j.jacc.2006.05.063
10.1124/mol.65.5.1238
10.1152/ajpheart.00651.2005
10.1007/BF00404342
10.1038/nm1102-1249
10.1038/414813a
10.1161/01.ATV.20.7.1745
10.1016/j.jacc.2006.01.001
10.2337/db06-1003
10.1016/S0735-1097(98)00286-1
10.2337/diabetes.54.6.1615
10.1007/s12012-007-9001-z
10.1161/01.ATV.0000258868.80079.4d
10.1006/abbi.2001.2331
10.1210/er.2004-0028
10.1016/j.ejphar.2008.02.072
10.1248/cpb.50.1135
10.1056/NEJM200001203420302
10.1161/CIRCRESAHA.109.200568
10.1038/35008121
10.1172/JCI4711
10.1097/01.ASN.0000051660.82593.19
10.1177/0091270005282630
10.1007/s00418-004-0678-9
10.1254/jphs.FP0040404
10.1016/j.ijcard.2005.10.026
10.1016/j.freeradbiomed.2007.02.017
10.1161/01.RES.0000029970.97247.57
10.1016/j.molmed.2004.09.003
ContentType Journal Article
Copyright Elsevier Ireland Ltd
2010 Elsevier Ireland Ltd
2015 INIST-CNRS
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Copyright_xml – notice: Elsevier Ireland Ltd
– notice: 2010 Elsevier Ireland Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.atherosclerosis.2010.01.035
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1484
EndPage 76
ExternalDocumentID 10_1016_j_atherosclerosis_2010_01_035
20172524
23056072
S0021915010000833
1_s2_0_S0021915010000833
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
0R
0SF
1
1-
1B1
1P
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
55
5GY
5RE
5VS
7-5
71M
8P
9JM
AABNK
AACTN
AAEDT
AAIAV
AAIKJ
AAKOC
AALMO
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABFLS
ABFNM
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABPIF
ABWYI
ABXDB
ABYKQ
ACDAQ
ACGFS
ACIUM
ACRLP
ADALY
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFFNX
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FO
G-
G-2
G-Q
GBLVA
GJ
HEB
HMK
HMO
HVGLF
HZ
IHE
IPNFZ
J1W
J5H
K
K-O
KM
KOM
L7B
LCYCR
M
M27
M41
MO0
N9A
NCXOZ
O-L
O9-
OA
OAUVE
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZA5
ZGI
ZXP
---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1P~
8P~
AAEDW
ABJNI
AHPSJ
AXJTR
EFLBG
FYGXN
HZ~
OA~
~G-
~KM
AAUGY
IQODW
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c539t-4cd3093fa71415f86800b628ed4e1991bbd1e29453c8ee2d93a4f89c804f09483
IEDL.DBID .~1
ISSN 0021-9150
IngestDate Fri Aug 16 07:17:04 EDT 2024
Thu Sep 26 19:07:18 EDT 2024
Sat Sep 28 07:46:48 EDT 2024
Sun Oct 22 16:06:15 EDT 2023
Fri Feb 23 02:28:05 EST 2024
Thu Aug 18 19:11:57 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Magnesium lithospermate B
Oxidative stress
Nrf2
Diabetes mellitus
Diabetic atherosclerosis
Endocrinopathy
Vascular disease
Prevention
Atherosclerosis
Cardiovascular disease
Magnesium
Inorganic element
Language English
License CC BY 4.0
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-4cd3093fa71415f86800b628ed4e1991bbd1e29453c8ee2d93a4f89c804f09483
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20172524
PQID 733977300
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_733977300
crossref_primary_10_1016_j_atherosclerosis_2010_01_035
pubmed_primary_20172524
pascalfrancis_primary_23056072
elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2010_01_035
elsevier_clinicalkeyesjournals_1_s2_0_S0021915010000833
PublicationCentury 2000
PublicationDate 2010-07-01
PublicationDateYYYYMMDD 2010-07-01
PublicationDate_xml – month: 07
  year: 2010
  text: 2010-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2010
Publisher Elsevier Ireland Ltd
Elsevier
Publisher_xml – name: Elsevier Ireland Ltd
– name: Elsevier
References Kikkawa, Haneda, Uzu, Koya, Sugimoto, Shigeta (bib16) 1994; 37
Brownlee (bib22) 2005; 54
Ruef, Liu, Bode (bib23) 2000; 20
Nishikawa, Edelstein, Du (bib4) 2000; 404
Abizaid, Kornowski, Mintz (bib19) 1998; 32
Cheng (bib6) 2006; 113
King, Loeken (bib3) 2004; 122
Hur, Seo, Kang (bib10) 2008; 586
Levonen, Inkala, Heikura (bib27) 2007; 27
Yusuf, Dagenais, Pogue, Bosch, Sleight, Vitamin (bib5) 2000; 342
Motohashi, Yamamoto (bib20) 2004; 10
Xue, Qian, Adaikalakoteswari, Rabbani, Babaei-Jadidi, Thornalley (bib28) 2008; 57
Zhu, Jia, Mahaney (bib30) 2007; 7
Siegel, Gustafson, Dehn (bib29) 2004; 65
Srivastava, Ramana, Bhatnagar (bib12) 2005; 26
Chen, Dodd, Thomas (bib26) 2006; 290
Evans, Goldfine, Maddux, Grodsky (bib2) 2002; 23
Rittner, Hafner, Klimiuk, Szweda, Goronzy, Weyand (bib24) 1999; 103
Tanigawa, Fujii, Hou (bib17) 2007; 42
Yan, Harja, Andrassy, Fujita, Schmidt (bib14) 2006; 48
Cheng (bib8) 2006; 47
Lee, Ha, Jung (bib11) 2003; 14
Shinmura, Bolli, Liu (bib15) 2002; 91
Akimoto, Kreppel, Hirano, Hart (bib13) 2001; 389
Brownlee (bib1) 2001; 414
Srivastava, Vladykovskaya, Barski (bib25) 2009; 105
Nishinaka, Yabe-Nishimura (bib21) 2005; 97
Jung, Lee, Ahn (bib9) 2002; 50
Dzau, Braun-Dullaeus, Sedding (bib18) 2002; 8
Zhou, Zuo, Chow (bib7) 2005; 45
Nishikawa (10.1016/j.atherosclerosis.2010.01.035_bib4) 2000; 404
Brownlee (10.1016/j.atherosclerosis.2010.01.035_bib1) 2001; 414
Cheng (10.1016/j.atherosclerosis.2010.01.035_bib6) 2006; 113
Levonen (10.1016/j.atherosclerosis.2010.01.035_bib27) 2007; 27
Srivastava (10.1016/j.atherosclerosis.2010.01.035_bib12) 2005; 26
Motohashi (10.1016/j.atherosclerosis.2010.01.035_bib20) 2004; 10
Ruef (10.1016/j.atherosclerosis.2010.01.035_bib23) 2000; 20
Kikkawa (10.1016/j.atherosclerosis.2010.01.035_bib16) 1994; 37
Yan (10.1016/j.atherosclerosis.2010.01.035_bib14) 2006; 48
Zhu (10.1016/j.atherosclerosis.2010.01.035_bib30) 2007; 7
Yusuf (10.1016/j.atherosclerosis.2010.01.035_bib5) 2000; 342
Xue (10.1016/j.atherosclerosis.2010.01.035_bib28) 2008; 57
Abizaid (10.1016/j.atherosclerosis.2010.01.035_bib19) 1998; 32
Lee (10.1016/j.atherosclerosis.2010.01.035_bib11) 2003; 14
Hur (10.1016/j.atherosclerosis.2010.01.035_bib10) 2008; 586
Siegel (10.1016/j.atherosclerosis.2010.01.035_bib29) 2004; 65
King (10.1016/j.atherosclerosis.2010.01.035_bib3) 2004; 122
Chen (10.1016/j.atherosclerosis.2010.01.035_bib26) 2006; 290
Nishinaka (10.1016/j.atherosclerosis.2010.01.035_bib21) 2005; 97
Evans (10.1016/j.atherosclerosis.2010.01.035_bib2) 2002; 23
Brownlee (10.1016/j.atherosclerosis.2010.01.035_bib22) 2005; 54
Cheng (10.1016/j.atherosclerosis.2010.01.035_bib8) 2006; 47
Akimoto (10.1016/j.atherosclerosis.2010.01.035_bib13) 2001; 389
Tanigawa (10.1016/j.atherosclerosis.2010.01.035_bib17) 2007; 42
Srivastava (10.1016/j.atherosclerosis.2010.01.035_bib25) 2009; 105
Dzau (10.1016/j.atherosclerosis.2010.01.035_bib18) 2002; 8
Zhou (10.1016/j.atherosclerosis.2010.01.035_bib7) 2005; 45
Shinmura (10.1016/j.atherosclerosis.2010.01.035_bib15) 2002; 91
Rittner (10.1016/j.atherosclerosis.2010.01.035_bib24) 1999; 103
Jung (10.1016/j.atherosclerosis.2010.01.035_bib9) 2002; 50
References_xml – volume: 54
  start-page: 1615
  year: 2005
  end-page: 1625
  ident: bib22
  article-title: The pathobiology of diabetic complications: a unifying mechanism
  publication-title: Diabetes
  contributor:
    fullname: Brownlee
– volume: 103
  start-page: 1007
  year: 1999
  end-page: 1013
  ident: bib24
  article-title: Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis
  publication-title: J Clin Invest
  contributor:
    fullname: Weyand
– volume: 290
  start-page: H1862
  year: 2006
  end-page: H1870
  ident: bib26
  article-title: Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression
  publication-title: Am J Physiol Heart Circ Physiol
  contributor:
    fullname: Thomas
– volume: 23
  start-page: 599
  year: 2002
  end-page: 622
  ident: bib2
  article-title: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes
  publication-title: Endocr Rev
  contributor:
    fullname: Grodsky
– volume: 57
  start-page: 2809
  year: 2008
  end-page: 2817
  ident: bib28
  article-title: Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease
  publication-title: Diabetes
  contributor:
    fullname: Thornalley
– volume: 45
  start-page: 1345
  year: 2005
  end-page: 1359
  ident: bib7
  article-title: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
  publication-title: J Clin Pharmacol
  contributor:
    fullname: Chow
– volume: 42
  start-page: 1690
  year: 2007
  end-page: 1703
  ident: bib17
  article-title: Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin
  publication-title: Free Radic Biol Med
  contributor:
    fullname: Hou
– volume: 8
  start-page: 1249
  year: 2002
  end-page: 1256
  ident: bib18
  article-title: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies
  publication-title: Nat Med
  contributor:
    fullname: Sedding
– volume: 32
  start-page: 584
  year: 1998
  end-page: 589
  ident: bib19
  article-title: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Mintz
– volume: 113
  start-page: 437
  year: 2006
  end-page: 438
  ident: bib6
  article-title: Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease
  publication-title: Int J Cardiol
  contributor:
    fullname: Cheng
– volume: 404
  start-page: 787
  year: 2000
  end-page: 790
  ident: bib4
  article-title: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
  publication-title: Nature
  contributor:
    fullname: Du
– volume: 47
  start-page: 1498
  year: 2006
  ident: bib8
  article-title: Danshen: a popular chinese cardiac herbal drug
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Cheng
– volume: 65
  start-page: 1238
  year: 2004
  end-page: 1247
  ident: bib29
  article-title: NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger
  publication-title: Mol Pharmacol
  contributor:
    fullname: Dehn
– volume: 50
  start-page: 1135
  year: 2002
  end-page: 1136
  ident: bib9
  article-title: Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line
  publication-title: Chem Pharm Bull (Tokyo)
  contributor:
    fullname: Ahn
– volume: 48
  start-page: A47
  year: 2006
  end-page: 55
  ident: bib14
  article-title: Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Schmidt
– volume: 7
  start-page: 202
  year: 2007
  end-page: 211
  ident: bib30
  article-title: The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger
  publication-title: Cardiovasc Toxicol
  contributor:
    fullname: Mahaney
– volume: 10
  start-page: 549
  year: 2004
  end-page: 557
  ident: bib20
  article-title: Nrf2-Keap1 defines a physiologically important stress response mechanism
  publication-title: Trends Mol Med
  contributor:
    fullname: Yamamoto
– volume: 586
  start-page: 226
  year: 2008
  end-page: 233
  ident: bib10
  article-title: Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Kang
– volume: 97
  start-page: 43
  year: 2005
  end-page: 51
  ident: bib21
  article-title: Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene
  publication-title: J Pharmacol Sci
  contributor:
    fullname: Yabe-Nishimura
– volume: 122
  start-page: 333
  year: 2004
  end-page: 338
  ident: bib3
  article-title: Hyperglycemia-induced oxidative stress in diabetic complications
  publication-title: Histochem Cell Biol
  contributor:
    fullname: Loeken
– volume: 91
  start-page: 240
  year: 2002
  end-page: 246
  ident: bib15
  article-title: Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning
  publication-title: Circ Res
  contributor:
    fullname: Liu
– volume: 20
  start-page: 1745
  year: 2000
  end-page: 1752
  ident: bib23
  article-title: Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury
  publication-title: Arterioscler Thromb Vasc Biol
  contributor:
    fullname: Bode
– volume: 414
  start-page: 813
  year: 2001
  end-page: 820
  ident: bib1
  article-title: Biochemistry and molecular cell biology of diabetic complications
  publication-title: Nature
  contributor:
    fullname: Brownlee
– volume: 342
  start-page: 154
  year: 2000
  end-page: 160
  ident: bib5
  article-title: E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators
  publication-title: N Engl J Med
  contributor:
    fullname: Vitamin
– volume: 14
  start-page: 709
  year: 2003
  end-page: 720
  ident: bib11
  article-title: Delayed treatment with lithospermate B attenuates experimental diabetic renal injury
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Jung
– volume: 389
  start-page: 166
  year: 2001
  end-page: 175
  ident: bib13
  article-title: Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation
  publication-title: Arch Biochem Biophys
  contributor:
    fullname: Hart
– volume: 26
  start-page: 380
  year: 2005
  end-page: 392
  ident: bib12
  article-title: Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options
  publication-title: Endocr Rev
  contributor:
    fullname: Bhatnagar
– volume: 37
  start-page: 838
  year: 1994
  end-page: 841
  ident: bib16
  article-title: Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions
  publication-title: Diabetologia
  contributor:
    fullname: Shigeta
– volume: 105
  start-page: 793
  year: 2009
  end-page: 802
  ident: bib25
  article-title: Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice
  publication-title: Circ Res
  contributor:
    fullname: Barski
– volume: 27
  start-page: 741
  year: 2007
  end-page: 747
  ident: bib27
  article-title: Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo
  publication-title: Arterioscler Thromb Vasc Biol
  contributor:
    fullname: Heikura
– volume: 23
  start-page: 599
  year: 2002
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib2
  article-title: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes
  publication-title: Endocr Rev
  doi: 10.1210/er.2001-0039
  contributor:
    fullname: Evans
– volume: 48
  start-page: A47
  year: 2006
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib14
  article-title: Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.05.063
  contributor:
    fullname: Yan
– volume: 65
  start-page: 1238
  year: 2004
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib29
  article-title: NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.65.5.1238
  contributor:
    fullname: Siegel
– volume: 290
  start-page: H1862
  year: 2006
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib26
  article-title: Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00651.2005
  contributor:
    fullname: Chen
– volume: 37
  start-page: 838
  year: 1994
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib16
  article-title: Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions
  publication-title: Diabetologia
  doi: 10.1007/BF00404342
  contributor:
    fullname: Kikkawa
– volume: 8
  start-page: 1249
  year: 2002
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib18
  article-title: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies
  publication-title: Nat Med
  doi: 10.1038/nm1102-1249
  contributor:
    fullname: Dzau
– volume: 414
  start-page: 813
  year: 2001
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib1
  article-title: Biochemistry and molecular cell biology of diabetic complications
  publication-title: Nature
  doi: 10.1038/414813a
  contributor:
    fullname: Brownlee
– volume: 20
  start-page: 1745
  year: 2000
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib23
  article-title: Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.7.1745
  contributor:
    fullname: Ruef
– volume: 47
  start-page: 1498
  year: 2006
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib8
  article-title: Danshen: a popular chinese cardiac herbal drug
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.01.001
  contributor:
    fullname: Cheng
– volume: 57
  start-page: 2809
  year: 2008
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib28
  article-title: Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease
  publication-title: Diabetes
  doi: 10.2337/db06-1003
  contributor:
    fullname: Xue
– volume: 32
  start-page: 584
  year: 1998
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib19
  article-title: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(98)00286-1
  contributor:
    fullname: Abizaid
– volume: 54
  start-page: 1615
  year: 2005
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib22
  article-title: The pathobiology of diabetic complications: a unifying mechanism
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.6.1615
  contributor:
    fullname: Brownlee
– volume: 7
  start-page: 202
  year: 2007
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib30
  article-title: The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger
  publication-title: Cardiovasc Toxicol
  doi: 10.1007/s12012-007-9001-z
  contributor:
    fullname: Zhu
– volume: 27
  start-page: 741
  year: 2007
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib27
  article-title: Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000258868.80079.4d
  contributor:
    fullname: Levonen
– volume: 389
  start-page: 166
  year: 2001
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib13
  article-title: Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.2001.2331
  contributor:
    fullname: Akimoto
– volume: 26
  start-page: 380
  year: 2005
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib12
  article-title: Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options
  publication-title: Endocr Rev
  doi: 10.1210/er.2004-0028
  contributor:
    fullname: Srivastava
– volume: 586
  start-page: 226
  year: 2008
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib10
  article-title: Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2008.02.072
  contributor:
    fullname: Hur
– volume: 50
  start-page: 1135
  year: 2002
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib9
  article-title: Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line
  publication-title: Chem Pharm Bull (Tokyo)
  doi: 10.1248/cpb.50.1135
  contributor:
    fullname: Jung
– volume: 342
  start-page: 154
  year: 2000
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib5
  article-title: E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200001203420302
  contributor:
    fullname: Yusuf
– volume: 105
  start-page: 793
  year: 2009
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib25
  article-title: Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.109.200568
  contributor:
    fullname: Srivastava
– volume: 404
  start-page: 787
  year: 2000
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib4
  article-title: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
  publication-title: Nature
  doi: 10.1038/35008121
  contributor:
    fullname: Nishikawa
– volume: 103
  start-page: 1007
  year: 1999
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib24
  article-title: Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis
  publication-title: J Clin Invest
  doi: 10.1172/JCI4711
  contributor:
    fullname: Rittner
– volume: 14
  start-page: 709
  year: 2003
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib11
  article-title: Delayed treatment with lithospermate B attenuates experimental diabetic renal injury
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000051660.82593.19
  contributor:
    fullname: Lee
– volume: 45
  start-page: 1345
  year: 2005
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib7
  article-title: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
  publication-title: J Clin Pharmacol
  doi: 10.1177/0091270005282630
  contributor:
    fullname: Zhou
– volume: 122
  start-page: 333
  year: 2004
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib3
  article-title: Hyperglycemia-induced oxidative stress in diabetic complications
  publication-title: Histochem Cell Biol
  doi: 10.1007/s00418-004-0678-9
  contributor:
    fullname: King
– volume: 97
  start-page: 43
  year: 2005
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib21
  article-title: Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene
  publication-title: J Pharmacol Sci
  doi: 10.1254/jphs.FP0040404
  contributor:
    fullname: Nishinaka
– volume: 113
  start-page: 437
  year: 2006
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib6
  article-title: Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2005.10.026
  contributor:
    fullname: Cheng
– volume: 42
  start-page: 1690
  year: 2007
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib17
  article-title: Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2007.02.017
  contributor:
    fullname: Tanigawa
– volume: 91
  start-page: 240
  year: 2002
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib15
  article-title: Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000029970.97247.57
  contributor:
    fullname: Shinmura
– volume: 10
  start-page: 549
  year: 2004
  ident: 10.1016/j.atherosclerosis.2010.01.035_bib20
  article-title: Nrf2-Keap1 defines a physiologically important stress response mechanism
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2004.09.003
  contributor:
    fullname: Motohashi
SSID ssj0004718
Score 2.2671108
Snippet Abstract Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including...
Hyperglycemia-induced oxidative stress is known to play an important role in the development of several diabetic complications, including atherosclerosis....
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 69
SubjectTerms Aldehyde Reductase - metabolism
Animals
Antioxidants - pharmacology
Associated diseases and complications
Atherosclerosis (general aspects, experimental research)
Atherosclerosis - metabolism
Atherosclerosis - prevention & control
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular
Diabetes mellitus
Diabetes Mellitus, Experimental - complications
Diabetes. Impaired glucose tolerance
Diabetic atherosclerosis
Drugs, Chinese Herbal - therapeutic use
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Magnesium lithospermate B
Male
Medical sciences
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - metabolism
NAD(P)H Dehydrogenase (Quinone) - physiology
NF-E2-Related Factor 2 - physiology
Nrf2
Oxidative stress
Oxidative Stress - drug effects
Protein Kinase C - metabolism
Rats
Rats, Sprague-Dawley
Response Elements - physiology
Title Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0021915010000833
https://dx.doi.org/10.1016/j.atherosclerosis.2010.01.035
https://www.ncbi.nlm.nih.gov/pubmed/20172524
https://search.proquest.com/docview/733977300
Volume 211
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PSxwxFH6IghRKsfbX2nbJoT1GZ5LMTubWVZSt4lZLBW8hM0nsFNxdnF1LPfi3-zLJuGhbKPQyh2F-JHkv3_uSfHkB-JDrLJMu4dQnd6JiwAUtnDOUmyo3pUBDl222z_FgdCYOz7PzFdjr9sJ4WWXE_oDpLVrHOzuxNXdmde33-GJvQz7TzlBL7jN-CgxG6NPbt0uZhwffIPNIqX96HT4uNV4tyZo2-Em81k1UeqXbSXv62x_j1NOZbrD1XDj24u-8tI1PBxvwLBJLMgxlfw4rdrIJ68dx6fwF3JyEjAyIbiSKOMjUkUt9gWBXLy4J8vHvbd5w5LCW7BJ9oWvkjiTMztYVeVQNcl1rMr5yjA6_7tPx6ZeUzH3g62AIC-OPO_6pf72Es4P9b3sjGg9eoFXGizkVlfELpE7nKcZ3JwfSm4xJa4T1UqmyNKllhch4Ja1lpuBaOFlUMhEOh4uSv4LVyXRi3wApXZ6bFB_jFjFZI93JKsM08kpZlsg-ejDomlnNQn4N1QnPfqhHFVPePipJFdqnB3lnFNVtIkXYs03sg41KVcNUon7zkx58un_zgaspjCL_-vP-Aze4LzrzI7IkZz0gnV8o7K9-EUZP7HTRqJx7ys0TrPnr4C_Ll_14PGNi6_8L-BaeBJmD1xW_g9X51cK-R_Y0L_tt9-jD2vDz0Wh8B6L7HMI
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VrVSQEOLd5VF8gKNpEjtr58ZStdrSNjzUSr1ZTmyXVOruqtkFwa9nHDtdtYCExCWHKE7smfHnz_HnMcBrofNcuoRRn9yJ8hHjtHDOUGZqYSqOjq66bJ_laHLCP5zmp2uw0--F8bLKiP0B0zu0jne2ozW3503j9_hib0M-0_2hlozdgnWei5QPYH28fzApV9sjRRoA2asRsMAGvFnJvDqeNWvxrXht2ij2St8m3QFwfxyq7s51iwZ04eSLv1PTbojauw_3Irck41D9B7Bmpw9h4yiunj-Cn59CUgYEOBJ1HGTmyIU-Q7xrlhcEKfnXLnU40lhL3hN9phukjyT8oG1qcqMZ5FujSXnpMjr-skvLzx9TsvBjX49EWBl_4vF3_eMxnOztHu9MaDx7gdY5KxaU18avkTqNBk1zJ0fSey2T1nDr1VJVZVKbFTxntbQ2MwXT3Mmilgl3OGOU7AkMprOp3QRSOSFMio8xi7CskfHktck0UktZVUhAhjDqzazmIcWG6rVn5-pGw5T3j0pShf4Zguidovp9pIh8to3dsFWpajOVqN9CZQjvrkpeizaFA8m_fnzrWhhcVT3zk7JEZEMgfVwo7LJ-HUZP7WzZKsE862YJtvxpiJdVYT8lzzP-7P8r-ApuT46PDtXhfnnwHO4E1YOXGb-AweJyaV8imVpUW7Gz_AJaBR94
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protective+effects+of+magnesium+lithospermate+B+against+diabetic+atherosclerosis+via+Nrf2-ARE-NQO1+transcriptional+pathway&rft.jtitle=Atherosclerosis&rft.au=Hur%2C+Kyu+Yeon&rft.au=Kim%2C+Soo+Hyun&rft.au=Choi%2C+Min-Ah&rft.au=Williams%2C+Darren+R.&rft.date=2010-07-01&rft.issn=0021-9150&rft.volume=211&rft.issue=1&rft.spage=69&rft.epage=76&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2010.01.035&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_atherosclerosis_2010_01_035
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219150%2FS0021915010X00077%2Fcov150h.gif